CinCor Pharma Overview
- Founded
- 2018

- Status
- Public
- Employees
- 10

- Stock Symbol
- CINC

- Share Price
- $27.15
- (As of Monday Closing)
CinCor Pharma General Information
Description
CinCor Pharma Inc is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases.
Contact Information
- 200 Clarendon Street
- 6th Floor
- Boston, MA 02116
- United States
CinCor Pharma Timeline
CinCor Pharma Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$27.15 | $25.03 | $13.01 - $30.66 | $914M | 36.5M | 275K | -$1.08 |
CinCor Pharma Financials Summary
In Thousands, USD |
TTM 30-Sep-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|
Revenue | 0 | 0 | 0 |
EBITDA | (22,335) | (5,137) | |
Net Income | (26,835) | (22,299) | (5,035) |
Total Assets | 147,264 | 26,800 | 11,924 |
Total Debt | 0 | 0 | 0 |
CinCor Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore CinCor Pharma‘s full profile, request access.
Request a free trialCinCor Pharma Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
This information is available in the PitchBook Platform. To explore CinCor Pharma‘s full profile, request access.
Request a free trialCinCor Pharma Comparisons
Industry
00000000
000000 0
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCinCor Pharma Competitors (61)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Apeptico | Venture Capital-Backed | Vienna, Austria | 00.000 | 00000000000 | 00.000 | |
000000 00000000000 | Formerly VC-backed | Watertown, MA | 00 | 000.00 | 000000&0 | 000.00 |
0000000 0000000000 | Formerly VC-backed | Boston, MA | 0 | 00000 | 000000000 | 00000 |
0000000 000 | Venture Capital-Backed | San Diego, CA | 00 | 000.00 | 00000000000 | 000.00 |
000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
CinCor Pharma Executive Team (7)
CinCor Pharma Board Members (10)
Name | Representing | Role | Since |
---|---|---|---|
August Troendle MD | Self | Board Member | 000 0000 |
David Allison Ph.D | 5AM Ventures | Board Member | 000 0000 |
James Healy MD | Sofinnova Investments | Chairman | 000 0000 |
Jason Pitts Ph.D | General Atlantic | Board Member | 000 0000 |
John Thero | CinCor Pharma | Board Member | 000 0000 |
CinCor Pharma Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial